• Health Care Enforcement Review and 2017 Outlook: Part 4
  • March 9, 2017 | Authors: Brian P. Dunphy; Karen S. Lovitch; Kevin M. McGinty
  • Law Firm: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. - Boston Office
  • Law360, New York (January 19, 2017, 10:39 AM EST) - In part 1 of our four-part health care enforcement review and 2017 outlook series, we examined the U.S. Food and Drug Administration's wide-ranging enforcement activities related to health care fraud. Part 2 addressed 2016's major case developments in health care enforcement and part 3 highlighted significant regulatory developments in this area.